Jungles, islands, big cats: climb aboard the revamped Eastern & Oriental Express to strike out on an adventure across ...

How do you decide what you need, how much to spend and what's "you"? These are some of the questions we're putting to ...

Prasenjeet Yadav photographed this rarely seen black tiger at the Similipal Tiger Reserve in India. A black tiger — known for its merged stripes — patrols the Similipal Tiger Reserve in Odisha ...

LONDON — Patou’s creative director Guillaume Henry has dreamed up a world of cotton candy pink for its collaboration with Onitsuka Tiger. At the Japanese sports fashion brand’s Regent Street ...

The latest B.C. bomb cyclone will create additional disruptions on Wednesday as it continues to make its notable presence felt An exceptional, rapidly intensifying storm caused closures and power ...

HS, for one, is an “extraordinarily painful” disease with a lengthy diagnosis process and few treatment options, UCB’s head of U.S. immunology Camille Lee said in an interview with Fierce ...

I’ve never really been cool, and this fact has always bugged me. I’m not telling you this to sound charming or self-deprecating—it’s just the truth. One Monday in third grade, Maggie and ...

A video of the incident, which went viral on social media on Tuesday, shows the man stepping into the street, spotting the tiger, and rushing back to shut a large iron gate, just as the massive cat ...

Shortly before the farmer’s lucky escape, the big cat had attacked another person in the village A Chinese farmer had a lucky escape after a rare Siberian tiger hurled itself against the gate of ...

This March, Chhattisgarh’s Barnawapara Wildlife Sanctuary had an unusual visitor – a young male tiger who has now made the forest his new home. For a jungle that hasn’t hosted tigers for nearly 40 ...

Two months after Roche scored FDA approval for its subcutaneous version of PD-LI inhibitor Tecentriq, Merck has achieved a key milestone in lining up its checkpoint inhibitor Keytruda to follow suit.

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...